SOAT1 and acute myeloid leukemia: Consistent with a role for IL-6 signaling in treatment resistance, inhibition of JAK/STAT signaling sensitizes AML blasts to treatment with other drugs16, as well as reducing the proliferation rate of adult AML cells17.